Diego de Aragão Bezerra De Aragão Bezerra

Diego de Aragão Bezerra De Aragão Bezerra

Auto-generated profile, based on publicly available information

Diego de Aragão Bezerra De Aragão Bezerra

UNIVERSIDADE FEDERAL DO CEARÁ - CAMPUS DE SOBRAL

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2020 in Revista de Ciências Médicas e Biológicas
Verified
Journal Article
Closed access
PDF file
DBDiego de Aragão Bezerra De Aragão Bezerra
Diego de Aragão Bezerra De Aragão Bezerra
JLJose Juvenal Linhares
Jose Juvenal Linhares
ENEmmanuelle Coelho Noronha
Emmanuelle Coelho Noronha
KTKaio César Simiano Tavares
Kaio César Simiano Tavares
AAAndré Saraiva Leão Marcelo Antunes
André Saraiva Leão Marcelo Antunes
MMMarcos Vinícius Souza Marques
Marcos Vinícius Souza Marques
Introduction: breast cancer (BC) is the most common tumor and the leading cause of cancer-related death among the female populationworldwide. Polymorphisms genetics of ABCB1 gene contributed to breast cancer susceptibility and interindividual differences inchemotherapy response. Objectives: to evaluate the association between the ABCB1 C3435T gene polymorphism (SNPs) with theresponse to neoadjuvant chemotherapy in women with breast cancer. Methodology: this study included 32 female patients whoreceived neoadjuvant chemotherapy. The polymorphisms were genotyped through real-time allele-specific polymerase chain reaction(PCR). The statistical analysis was performed using the Fisher’s exact test or Pearson’s chi-square test in the Statistical Package forSocial Sciences (SPSS) version 20.0 software. Results: the genotypes found for the C3435T polymorphism were in Hardy-Weinbergequilibrium and their genotypic distributions were CC= 10 (31.1%), CT= 14 (43.8%), and TT= 08 (25.0%) with χ2: 0.86 and p-value >0.05. Allele frequencies were C = 0.54 and T = 0.46. There were no significant statistical differences between genotypes considering theresponse to neoadjuvant chemotherapy and immunohistochemistry; the presence of the T allele was associated with worsen axillarystatus response to neoadjuvant chemotherapy. Conclusion: no definite association between the presence of C3435T polymorphismand the response to neoadjuvant chemotherapy was observed. Further studies in Brazil involving larger samples will contribute tovalidating the results of this study.